Brief: Strides Pharma Science Receives USFDA Approval For Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate Tablets
04/10/2023 11:33
Oct 4 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* STRIDES RECEIVES USFDA APPROVAL FOR EFAVIRENZ, EMTRICITABINE & TENOFOVIR
DISOPROXIL FUMURATE TABLETS
Further company coverage: SRID.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees